Answers are grounded in this paper and cite their sources.
BACKGROUND: Ablation of the incompetent saphenous vein may be accomplished by either surgical extirpation or ultrasound-guided sclerotherapy (UGS). Procedural guidelines for optimizing UGS outcome have yet to be established for this relatively new procedure. OBJECTIVE: To compare the effect of 1 vs 2 mL UGS sclerosant injectate volumes (SIV) on immediate vasospasm and later clinical outcome after UGS. METHODS: UGS was performed on 56 patients with Class C2-4EPASPR venous insufficiency and duplex-confirmed saphenous junctional incompetence using 3% sodium tetradecyl sulphate (STS) and Class II compression. Group 1 received 1 mL SIV, and group 2 received 2 mL SIV. Treatment endpoint for both groups was persistent vasospasm observed on duplex imaging (15 mL maximum), with clinical and duplex follow-up at 2 weeks, 6 months, and 12 months. RESULTS: The number of injections per treatment to achieve vasospasm (vasospastic dose) was unaffected by doubling the SIV. Group 2 had a higher recanalization rate than group 1. Several patients in group 2 experienced a transient febrile response shortly after treatment. CONCLUSIONS: Using our UGS protocol to treat saphenous junctional incompetence, 2 mL SIV was less effective than 1 mL SIV, and was associated a minor adverse effect. The larger SIV did not induce more rapid vasospasm, and therefore did not lead to a reduction in the number of injections per treatment. The maximum safe STS dose/session is unknown, and deserves scientific study.
No takes yet. Share an insight, caveat, or question.
A. Kanter (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: